VIB organizes the 4th edition of Applied Bioinformatics in Life Sciences

On March 10-11, the 4th edition of Applied Bioinformatics in Life Sciences will take place in the Provinciehuis in Leuven, Belgium.

Bioinformatics has quickly become an integral part of life sciences research by enabling innovative computational approaches in an increasingly data-dense environment. Inspired by the sold-out editions in 2016, 2018, and 2020, VIB is organizing this fourth edition to highlight recent developments in bioinformatics research and to showcase its impact on medical, agricultural, and biotechnological research.

Alex Botzki, Head of the VIB Informatics Core, launched this VIB Bioinformatics series in 2016:

‘I am happy to see the Applied Bioinformatics conference series evolve over the past years by following latest developments in computational biology which set the scene for more and more breakthroughs in modern data-intensive life sciences research.’

The conference has attracted many internationally renowned speakers. Anna Kreshuk (Cell Biology and Biophysics, EMBL Heidelberg, DE) will open the session on Image analysis. Smita Krishnaswamy (Yale School of Medicine, US) ​ will focus on deep representation learning methods that are applied to a variety of datasets from cancer biology, immunology, … In the session ‘Proteomics and metabolomics’ Niko Beerenwinkel (ETH, Zurich, CH) will present ‘Computational analysis of tumor single-cell sequencing data’. ‘Integrative analysis of multi-omics data’ is the research topic of Britta Velten (German Cancer Research Center (DKFZ), DE & Wellcome Sanger Institute, UK).

In addition to the plenary presentations, 70 young researchers will present their work during one of the poster sessions. Over 200 people will join the conference live or virtually.

More info

 

Share

Latest stories

Website preview
RSV vaccines could offer protection against asthma
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have found that early-infancy infection with respiratory syncytial virus (RSV) increases the risk of developing childhood asthma
press.vib.be
Website preview
New immune process identified that may alleviate Alzheimer's disease
26 November 2025, Leuven, Belgium - Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer’s disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have now demonstrated the mechanism behind it for the first time. They showed that the ‘Fc fragment’ of this monoclonal antibody is essential for engaging microglia - the immune cells of the brain -, thus initiating the cellular machinery needed for plaque removal. This is the first direct mechanistic explanation for how this class of therapies works. It clarifies uncertainties in the field and offers a blueprint for developing safer, more effective Alzheimer’s treatments. The findings are published in Nature Neuroscience.
press.vib.be
Website preview
Belgian collaboration drives new momentum in amyloidosis care and research 
World Amyloidosis Day – 26 October | First benefit concert supports new Fund 
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be